Media Center
- No
-
Category
- Show all
- Press Release
- News Article
- PR Video
- CEO Story
- Title
- Author
- Time uploaded
- Views
- Likes
- 44
- Press Release
- Press Release PharmAbcine Announces Positive Results for Its Novel TIE2-Activating Antibody in GLP Toxicology Study
- PharmAbcine
- 27 Apr 2022
- Views2264
- 0
- 43
- Press Release
- Press Release PharmAbcine Strengthens Scientific Advisory Board with a World-Renowned Expert in Ophthalmology
- PharmAbcine
- 27 Apr 2022
- Views2191
- 0
- 42
- Press Release
- Press Release PharmAbcine Presents Updated Preclinical Data of Its Anti-VISTA Antibody Candidate at AACR 2022
- PharmAbcine
- 12 Apr 2022
- Views5403
- 0
- 41
- Press Release
- Press Release PharmAbcine to Present Updated Data of Its Anti-VISTA Antibody Candidate at AACR 2022
- PharmAbcine
- 9 Mar 2022
- Views2170
- 0
- 40
- Press Release
- Press Release PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial
- PharmAbcine
- 27 Feb 2022
- Views2763
- 0
- 39
- Press Release
- Press Release PharmAbcine Announces First Patient Enrolled and Dosed in the Phase II Clinical Trial for the Treatment of mTNBC
- PharmAbcine
- 28 Dec 2021
- Views2592
- 0
- 38
- Press Release
- Press Release PharmAbcineโs next-generation bispecific antibody drug discovery project wins a New Drug Development Fund from the government
- PharmAbcine
- 13 Dec 2021
- Views2277
- 0
- 37
- Press Release
- Press Release PharmAbcine to participate in J.P. Morgan Healthcare Conference and Biotech Showcase during โJ.P. Morgan Week 2022โ
- PharmAbcine
- 7 Dec 2021
- Views2322
- 0
- 36
- Press Release
- Press Release PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody
- PharmAbcine
- 20 Oct 2021
- Views1946
- 0
- 35
- Press Release
- Press Release PharmAbcine to Participate in BIO-Europe 2021
- PharmAbcine
- 21 Sep 2021
- Views1954
- 0